IL6 and hemophagocytic syndrome: This is illustrated by the case (Circuit 11, Figure 1B) of a patient who was treated with CytoSorb because of hemophagocytic syndrome, developed sepsis during treatment with CytoSorb, and had increasing IL-6 levels over time despite effective removal.